(“NeoGenomics” or the “Company”) (NASDAQ:NEO), a leading oncology testing services company, today provided financial guidance for fiscal year 2025 and updated its Long-Range Financial Plan. “We enter ...
A business plan that gives lenders an idea of how you plan to grow your business and how the funds will be used. Some lenders may have a more robust set of requirements for documentation that may ...